Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Jindal Cotex Ltd

JINDCOT
NSE
2.50
Company Overview
Alert
Watchlist
Note

Jindal Cotex Ltd

JINDCOT
NSE
2.50
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
11Cr
Close
Close Price
2.50
Industry
Industry
Trading
PE
Price To Earnings
PS
Price To Sales
2.10
Revenue
Revenue
5Cr
Rev Gr TTM
Revenue Growth TTM
53,600.00%
PAT Gr TTM
PAT Growth TTM
-168.13%
Peer Comparison
How does JINDCOT stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
JINDCOT
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Revenue
RevenueCr
220000000005
Growth YoY
Revenue Growth YoY%
-74.1-64.2-100.0-100.0-100.0-99.6-100.0
Expenses
ExpensesCr
2410011010016
Operating Profit
Operating ProfitCr
-22200-1-10-100-10
OPM
OPM%
-994.568.8-5,700.0-6.5
Other Income
Other IncomeCr
1151812019-5111
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
100000000000
PBT
PBTCr
922711008-6000
Tax
TaxCr
000000000000
PAT
PATCr
922711008-6000
Growth YoY
PAT Growth YoY%
6,976.1292.1473.6-94.2-99.2-116.4-100.11,008.2-904.2144.4300.0-101.7
NPM
NPM%
4,188.289.8-3,600.0-2.6
EPS
EPS
20.50.51.60.0-0.2-0.10.0-0.20.00.00.00.0

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024TTM
Revenue
RevenueCr
34819610117823484332915205
Growth
Revenue Growth%
-43.8-48.175.131.7-64.2-60.8-13.3-46.5-84.0-99.653,600.0
Expenses
ExpensesCr
34125311417924280342838227
Operating Profit
Operating ProfitCr
8-57-13-1-84-10-230-2-2
OPM
OPM%
2.2-29.2-12.4-0.8-3.54.5-2.31.1-150.01.8-21,300.0-28.1
Other Income
Other IncomeCr
3122216242131125-3
Interest Expense
Interest ExpenseCr
485962121111111
Depreciation
DepreciationCr
12192020206665000
PBT
PBTCr
-50-134-93-20-281316-5102112-6
Tax
TaxCr
000000000000
PAT
PATCr
-50-134-93-20-281316-5102112-6
Growth
PAT Growth%
-168.830.878.8-43.7145.725.2-131.02,121.7-89.2-82.5-397.9
NPM
NPM%
-14.3-68.6-91.5-11.1-12.115.449.3-17.6666.3451.419,300.0-107.1
EPS
EPS
-11.1-30.6-18.4-4.5-6.32.93.6-1.122.62.4-0.1

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital
Equity CapitalCr
454545454545454545454545
Reserves
ReservesCr
23660-33-49-72173328130141143143
Current Liabilities
Current LiabilitiesCr
2281621711878520141421977
Non Current Liabilities
Non Current LiabilitiesCr
31642547847559123721220951424141
Total Liabilities
Total LiabilitiesCr
828696665659645319304296246237236236
Current Assets
Current AssetsCr
392329319332370201194192189180179179
Non Current Assets
Non Current AssetsCr
43636734632727511811110457565757
Total Assets
Total AssetsCr
828696665659645319304296246237236236

Cash Flow

Consolidated
Standalone
Financial YearMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Operating Cash Flow
Operating Cash FlowCr
45-79-50269324311360
Investing Cash Flow
Investing Cash FlowCr
-32-611-3274224542
Financing Cash Flow
Financing Cash FlowCr
17346-5-3-374-26-4-159-10-2
Net Cash Flow
Net Cash FlowCr
13-12-3-30-701-100
Free Cash Flow
Free Cash FlowCr
31-67-4314922431578
CFO To PAT
CFO To PAT%
-89.458.654.3-10.2-22.3719.2149.5-68.8111.450.8-2.6
CFO To EBITDA
CFO To EBITDA%
587.8137.8401.9-147.8-75.82,487.3-3,190.81,062.4-494.912,620.12.4

Ratios

Consolidated
Standalone
Financial YearMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
683738593221911170
Price To Earnings
Price To Earnings
0.00.00.00.00.01.60.50.00.20.0
Price To Sales
Price To Sales
0.20.20.40.30.10.30.30.41.10.0
Price To Book
Price To Book
0.20.33.1-14.9-1.20.30.10.10.10.0
EV To EBITDA
EV To EBITDA
59.5-9.9-50.0-489.7-76.069.9-295.5681.7-3.11,020.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
17.924.423.222.621.123.735.239.343.382.1100.0
OPM
OPM%
2.2-29.2-12.4-0.8-3.54.5-2.31.1-150.01.8-21,300.0
NPM
NPM%
-14.3-68.6-91.5-11.1-12.115.449.3-17.6666.3451.419,300.0
ROCE
ROCE%
-0.3-11.7-5.0-3.1-4.64.55.8-1.544.85.31.3
ROE
ROE%
-17.8-128.0-771.2498.0105.520.920.8-6.958.25.91.0
ROA
ROA%
-6.0-19.3-13.9-3.0-4.44.05.3-1.741.34.70.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
This report provides a comprehensive overview of the company’s current standing, focusing on its governance framework, the total cessation of its industrial operations, and the critical financial and regulatory challenges it currently faces. --- ### **Governance Framework & Leadership Structure** Despite operational halts, the company maintains a formal corporate governance structure designed to oversee strategic decisions and regulatory compliance. The leadership model is built around a **Board of Directors** supported by specialized committees to ensure fiduciary responsibility. * **Board Composition & Expertise**: The board is composed of individuals with significant domain expertise, including directors with over **35 years** of experience in the industrial sector. The selection process emphasizes a **skill-based composition** to align with the specific requirements of the business services sector. * **Specialized Oversight Committees**: * **Audit Committee**: Responsible for financial oversight and internal controls. * **Nomination & Remuneration Committee (NRC)**: Manages the alignment of leadership capabilities with long-term business goals. * **Stakeholders Relationship Committee**: Focuses on safeguarding the interests of shareholders and other stakeholders. * **Independent Director Mandates**: * Independent Directors serve standard terms of **5 consecutive years**. * The current re-appointment cycle for key independent leadership spans from **September 29, 2023**, to **September 28, 2028**. * Appointments are formalized via **Special Resolution** by members. * To ensure continuity in strategic oversight, Independent Directors are **not liable to retire by rotation**. --- ### **Operational Status: Total Cessation of Activities** The company is currently in a state of operational paralysis, with all primary revenue-generating activities halted. * **Manufacturing Shutdown**: There are currently **no manufacturing activities** being conducted. The company’s core industrial facilities are inactive. * **Energy Sector Exit**: Operations at the **Jaisalmer wind mill** have been closed. This closure was necessitated by the non-payment of essential maintenance charges to **Suzlon**, the service provider. * **Subsidiary & Investment Uncertainty**: There is a lack of clarity regarding the company’s unquoted investments in its subsidiary, **Jindal International FZE**, and capital advances made to **K. Onishi & Co.**, as these have not been evaluated under current **Ind AS** standards. --- ### **Financial Distress & Debt Resolution Status** The company’s financial position is characterized by heavy indebtedness, **NPA (Non-Performing Asset)** classifications, and ongoing recovery actions by lenders. #### **Lender Relations and Recovery Actions** All accounts with banks and financial institutions are classified as **NPA**. Lenders have recalled all outstanding dues and initiated recovery proceedings under the **SARFAESI Act, 2002**. However, the company maintains a legal stance that certain debts to secured lenders are **barred by limitation**, as the defaults are older than **three years**. #### **Debt Settlement Progress (OTS)** The company is attempting to clear liabilities through **One Time Settlements (OTS)**, with the following status across various creditors: | Entity | Liability Type | Status | Financial Details | | :--- | :--- | :--- | :--- | | **Union Bank of India** | Secured Debt | **Defaulted on OTS** | **₹3.00 Crore** sanctioned; only **₹0.75 Crore** paid by March 2024. | | **Punjab & Sind Bank** | Secured Debt | **In Process** | Settlement negotiations are currently ongoing. | | **PSPCL (Electricity)** | Utility Dues | **Settled** | Old dues of **₹99.31 Lacs** paid in full. | | **Statutory Bodies** | VAT, ESI, EPF | **Outstanding** | Long-term liabilities remain unpaid. | #### **Contingent Liabilities & Guarantees** The company faces massive exposure through corporate guarantees provided to related entities, totaling **₹256.10 Crore**. These guarantees were issued to: 1. **Jindal Medicot Ltd**: Currently under **CIRP** (Corporate Insolvency Resolution Process). 2. **Jindal Specialty Textiles Ltd**. --- ### **Regulatory Compliance & Market Standing** The company is currently isolated from the capital markets due to a series of regulatory infractions and historical bans. * **Stock Exchange Suspension**: Trading of the company’s equity shares is suspended on both the **BSE** and **NSE**. This is a result of non-compliance with listing agreements, non-payment of annual listing fees, and outstanding fines. * **SEBI Restraint Order**: The company and its directors were barred from the securities market for a period of **five years**, effective **April 24, 2019**. While this period expired on **April 23, 2024**, the company has not yet formalized the removal of this barring and remains in the process of addressing the fallout. * **Audit Qualifications & "Emphasis of Matter"**: * **Balance Confirmations**: Auditors have noted the total absence of third-party confirmations for **Trade Receivables, Trade Payables, and Loans & Advances**. * **Employee Benefits**: The company has failed to apply **Ind AS 19** regarding employee benefits due to a lack of required actuarial valuations. * **Accounting Standards**: Non-application of **Ind AS** regarding unquoted investments and specific capital advances remains a critical transparency gap. --- ### **Strategic Risk Summary** Investors should note the following critical risk factors: * **Liquidity Risk**: Failure to meet **OTS** deadlines (e.g., Union Bank) suggests severe cash flow constraints. * **Legal Risk**: Ongoing **SARFAESI** actions and the potential for further litigation regarding the **₹256.10 Crore** in corporate guarantees. * **Compliance Risk**: Continued suspension from stock exchanges prevents any immediate liquidity for shareholders. * **Operational Risk**: The lack of any active manufacturing or energy production means the company currently has no organic path to revenue generation.